← FDA Drug Approvals (Drugs@FDA)

POSACONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2022-02-04

Drug application

FDA Application #

ANDA214476

Application type

Abbreviated New Drug Application (Generic)

Brand name

POSACONAZOLE

Generic name

POSACONAZOLE

Active ingredients

POSACONAZOLE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

Biocon Phama Inc.

First approval

2022-02-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown